These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 10547627)
1. Phase III interlaboratory study of FETAX. Part 3. FETAX validation using 12 compounds with and without an exogenous metabolic activation system. Bantle JA; Finch RA; Fort DJ; Stover EL; Hull M; Kumsher-King M; Gaudet-Hull AM J Appl Toxicol; 1999; 19(6):447-72. PubMed ID: 10547627 [TBL] [Abstract][Full Text] [Related]
3. Phase III interlaboratory study of FETAX, Part 2: interlaboratory validation of an exogenous metabolic activation system for frog embryo teratogenesis assay--Xenopus (FETAX). Fort DJ; Stover EL; Bantle JA; Rayburn JR; Hull MA; Finch RA; Burton DT; Turley SD; Dawson DA; Linder G; Buchwalter D; Dumont JN; Kumsher-King M; Gaudet-Hull AM Drug Chem Toxicol; 1998 Feb; 21(1):1-14. PubMed ID: 9530526 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of the developmental toxicity of five compounds with the frog embryo teratogenesis assay: Xenopus (FETAX) and a metabolic activation system. Fort DJ; James BL; Bantle JA J Appl Toxicol; 1989 Dec; 9(6):377-88. PubMed ID: 2613998 [TBL] [Abstract][Full Text] [Related]
5. Analysis of the mechanism of isoniazid-induced developmental toxicity with frog embryo teratogenesis assay: Xenopus (FETAX). Fort DJ; Bantle JA Teratog Carcinog Mutagen; 1990; 10(6):463-76. PubMed ID: 1982910 [TBL] [Abstract][Full Text] [Related]
6. Assessing the predictive validity of frog embryo teratogenesis assay-Xenopus (FETAX). Fort DJ; Stover EL; Farmer DR; Lemen JK Teratog Carcinog Mutagen; 2000; 20(2):87-98. PubMed ID: 10679752 [TBL] [Abstract][Full Text] [Related]
7. Further validation of FETAX: evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens. Bantle JA; Fort DJ; Rayburn JR; DeYoung DJ; Bush SJ Drug Chem Toxicol; 1990; 13(4):267-82. PubMed ID: 1703942 [TBL] [Abstract][Full Text] [Related]
8. Development of a metabolic activation system for the frog embryo teratogenesis assay: Xenopus (FETAX). Fort DJ; Dawson DA; Bantle JA Teratog Carcinog Mutagen; 1988; 8(5):251-63. PubMed ID: 2905834 [TBL] [Abstract][Full Text] [Related]
9. Initial interlaboratory validation study of FETAX: phase I testing. Bantle JA; Burton DT; Dawson DA; Dumont JN; Finch RA; Fort DJ; Linder G; Rayburn JR; Buchwalter D; Maurice MA J Appl Toxicol; 1994; 14(3):213-23. PubMed ID: 8083483 [TBL] [Abstract][Full Text] [Related]
10. Optimization of an exogenous metabolic activation system for FETAX. I. Post-isolation rat liver microsome mixtures. Fort DJ; Rogers RL; Stover EL; Finch RA Drug Chem Toxicol; 2001 May; 24(2):103-15. PubMed ID: 11360429 [TBL] [Abstract][Full Text] [Related]
11. Frog embryo teratogenesis assay on Xenopus and predictivity compared with in vivo mammalian studies. Leconte I; Mouche I Methods Mol Biol; 2013; 947():403-21. PubMed ID: 23138919 [TBL] [Abstract][Full Text] [Related]
12. Mineral deficiency and the use of the FETAX bioassay to study environmental teratogens. Garber EA J Appl Toxicol; 2002; 22(4):237-40. PubMed ID: 12210540 [TBL] [Abstract][Full Text] [Related]
13. Assessing the efficacy of an Aroclor 1254-induced exogenous metabolic activation system for FETAX. Fort DJ; Rayburn JR; DeYoung DJ; Bantle JA Drug Chem Toxicol; 1991; 14(1-2):143-60. PubMed ID: 1889373 [TBL] [Abstract][Full Text] [Related]
14. Teratogenic assessment of four solvents using the Frog Embryo Teratogenesis Assay--Xenopus (FETAX). Dresser TH; Rivera ER; Hoffmann FJ; Finch RA J Appl Toxicol; 1992 Feb; 12(1):49-56. PubMed ID: 1564253 [TBL] [Abstract][Full Text] [Related]
15. Evaluation of the developmental toxicity of caffeine and caffeine metabolites using the frog embryo teratogenesis assay--Xenopus (FETAX). Fort DJ; Stover EL; Propst TL; Faulkner BC; Vollmuth TA; Murray FJ Food Chem Toxicol; 1998 Jul; 36(7):591-600. PubMed ID: 9687966 [TBL] [Abstract][Full Text] [Related]
16. Enhancing the predictive validity of Frog Embryo Teratogenesis Assay--Xenopus (FETAX). Fort DJ; Paul RR J Appl Toxicol; 2002; 22(3):185-91. PubMed ID: 12015799 [TBL] [Abstract][Full Text] [Related]
17. Developmental toxicity, uptake and distribution of sodium chromate assayed by frog embryo teratogenesis assay-Xenopus(FETAX). Bosisio S; Fortaner S; Bellinetto S; Farina M; Del Torchio R; Prati M; Gornati R; Bernardini G; Sabbioni E Sci Total Environ; 2009 Sep; 407(18):5039-45. PubMed ID: 19540565 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the toxicity and teratogenity of six commercial textile dyes using the frog embryo teratogenesis assay-Xenopus. Birhanli A; Ozmen M Drug Chem Toxicol; 2005; 28(1):51-65. PubMed ID: 15720035 [TBL] [Abstract][Full Text] [Related]
19. Evaluation of the developmental toxicity of thalidomide using frog embryo teratogenesis assay-xenopus (FETAX): biotransformation and detoxification. Fort DJ; Stover EL; Bantle JA; Finch RA Teratog Carcinog Mutagen; 2000; 20(1):35-47. PubMed ID: 10607376 [TBL] [Abstract][Full Text] [Related]
20. Application of the FETAX protocol to assess the developmental toxicity of nonylphenol ethoxylate to Xenopus laevis and two Australian frogs. Mann RM; Bidwell JR Aquat Toxicol; 2000 Nov; 51(1):19-29. PubMed ID: 10998496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]